Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma.
Iida S, Izumi T, Komeno T, Terui Y, Chou T, Ikeda T, Berg D, Fukunaga S, Sugiura K, Sasaki M. Iida S, et al. Among authors: komeno t. Int J Clin Oncol. 2022 Jan;27(1):224-233. doi: 10.1007/s10147-021-02030-7. Epub 2021 Oct 2. Int J Clin Oncol. 2022. PMID: 34599726 Free PMC article. Clinical Trial.
A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial.
Ichinohe T, Kuroda Y, Okamoto S, Matsue K, Iida S, Sunami K, Komeno T, Suzuki K, Ando K, Taniwaki M, Tobinai K, Chou T, Kaneko H, Iwasaki H, Uemura C, Tamakoshi H, Zaki MH, Doerr T, Hagiwara S. Ichinohe T, et al. Among authors: komeno t. Exp Hematol Oncol. 2016 Apr 18;5:11. doi: 10.1186/s40164-016-0040-7. eCollection 2015. Exp Hematol Oncol. 2016. PMID: 27096106 Free PMC article.
Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients.
Yamasaki S, Kada A, Choi I, Iida H, Sekiguchi N, Harada N, Sawamura M, Shimomura T, Komeno T, Yano T, Yoshida I, Yoshida S, Sunami K, Hishita T, Takatsuki H, Ohshima K, Takeshita M, Saito AM, Iwasaki H, Nagai H. Yamasaki S, et al. Among authors: komeno t. EJHaem. 2020 Oct 15;1(2):507-516. doi: 10.1002/jha2.111. eCollection 2020 Nov. EJHaem. 2020. PMID: 35844987 Free PMC article.
Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma.
Nagai H, Shimomura T, Takeuchi M, Hanada S, Komeno T, Sunami K, Hidaka M, Yano T, Kitano K, Yoshida I, Inoue N, Saito A, Horibe K, Motitani S, Ichihara S, Watanabe T, Sawamura M. Nagai H, et al. Among authors: komeno t. Leuk Lymphoma. 2017 Dec;58(12):2845-2851. doi: 10.1080/10428194.2017.1319054. Epub 2017 May 16. Leuk Lymphoma. 2017. PMID: 28509595 Clinical Trial.
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever.
Yoshida I, Saito AM, Tanaka S, Choi I, Hidaka M, Miyata Y, Inoue Y, Yamasaki S, Kagoo T, Iida H, Niimi H, Komeno T, Yoshida C, Tajima F, Yamamoto H, Takase K, Ueno H, Shimomura T, Sakai T, Nakashima Y, Yoshida C, Kubonishi S, Sunami K, Yoshida S, Sakurai A, Kaneko Y, Miyazaki Y, Nagai H. Yoshida I, et al. Among authors: komeno t. Mycoses. 2020 Aug;63(8):794-801. doi: 10.1111/myc.13100. Epub 2020 May 28. Mycoses. 2020. PMID: 32391919 Free PMC article. Clinical Trial.
100 results